Prue Cowin

Prue has experience in the preparation and global enforcement of patent portfolios in key geographic markets (including Australia, Europe and the US); conducting patent due diligence; and providing freedom-to-operate; patentability, infringement and validity opinions. Prue specialises in the area of biopharmaceuticals (including antibodies), their use and methods for their manufacture.

Prue works with local and overseas companies (including SMEs and multi-nationals), research and academic institutions, as well as both brand and biosimilar companies to strategically protect their intellectual property and assist in bringing their products to market.

Prue has an extensive scientific background having graduated from Monash University with a Bachelor of Biomedical Science (Hons) before completing her PhD at Monash Institute of Medical Research (now Hudson Institute) investigating the effects of environmental chemicals on prostate disease. She also completed a post-doctoral fellowship at the Peter MacCallum Cancer Centre, where she conducted comprehensive studies investigating acquired chemo-resistance in ovarian cancer and was part of the international effort to sequence the ovarian cancer genome.

Prue is a registered Australian and New Zealand Patent Attorney.